174 related articles for article (PubMed ID: 10970063)
1. Recent advances in Huntington's disease.
Gutekunst CA; Norflus F; Hersch SM
Curr Opin Neurol; 2000 Aug; 13(4):445-50. PubMed ID: 10970063
[TBL] [Abstract][Full Text] [Related]
2. Recent advances on the pathogenesis of Huntington's disease.
Petersén A; Mani K; Brundin P
Exp Neurol; 1999 May; 157(1):1-18. PubMed ID: 10222105
[TBL] [Abstract][Full Text] [Related]
3. Animal models of Huntington's disease: from basic research on neuronal death to assessment of new therapeutic strategies.
Brouillet E
Funct Neurol; 2000; 15(4):239-51. PubMed ID: 11213527
[No Abstract] [Full Text] [Related]
4. Mutant huntingtin can paradoxically protect neurons from death.
Zuchner T; Brundin P
Cell Death Differ; 2008 Mar; 15(3):435-42. PubMed ID: 17975550
[TBL] [Abstract][Full Text] [Related]
5. The molecular biology of Huntington's disease.
Ho LW; Carmichael J; Swartz J; Wyttenbach A; Rankin J; Rubinsztein DC
Psychol Med; 2001 Jan; 31(1):3-14. PubMed ID: 11200958
[TBL] [Abstract][Full Text] [Related]
6. Antiglutamate therapies in Huntington's disease.
Kieburtz K
J Neural Transm Suppl; 1999; 55():97-102. PubMed ID: 10335496
[TBL] [Abstract][Full Text] [Related]
7. Weight loss in Huntington disease increases with higher CAG repeat number.
Aziz NA; van der Burg JM; Landwehrmeyer GB; Brundin P; Stijnen T; ; Roos RA
Neurology; 2008 Nov; 71(19):1506-13. PubMed ID: 18981372
[TBL] [Abstract][Full Text] [Related]
8. Huntington's disease: pathomechanism and therapeutic perspectives.
Gárdián G; Vécsei L
J Neural Transm (Vienna); 2004 Oct; 111(10-11):1485-94. PubMed ID: 15480847
[TBL] [Abstract][Full Text] [Related]
9. Murine Models of Huntington's Disease for Evaluating Therapeutics.
Kosior N; Leavitt BR
Methods Mol Biol; 2018; 1780():179-207. PubMed ID: 29856020
[TBL] [Abstract][Full Text] [Related]
10. Emerging chemotherapeutic strategies for Huntington's disease.
Ryu H; Ferrante RJ
Expert Opin Emerg Drugs; 2005 May; 10(2):345-63. PubMed ID: 15934871
[TBL] [Abstract][Full Text] [Related]
11. Viral delivery of glial cell line-derived neurotrophic factor improves behavior and protects striatal neurons in a mouse model of Huntington's disease.
McBride JL; Ramaswamy S; Gasmi M; Bartus RT; Herzog CD; Brandon EP; Zhou L; Pitzer MR; Berry-Kravis EM; Kordower JH
Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9345-50. PubMed ID: 16751280
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in understanding the pathogenesis of Huntington's disease.
Reddy PH; Williams M; Tagle DA
Trends Neurosci; 1999 Jun; 22(6):248-55. PubMed ID: 10354600
[TBL] [Abstract][Full Text] [Related]
13. Huntington's disease: progress and potential in the field.
Stack EC; Ferrante RJ
Expert Opin Investig Drugs; 2007 Dec; 16(12):1933-53. PubMed ID: 18042002
[TBL] [Abstract][Full Text] [Related]
14. Knock-in mouse models of Huntington's disease.
Menalled LB
NeuroRx; 2005 Jul; 2(3):465-70. PubMed ID: 16389309
[TBL] [Abstract][Full Text] [Related]
15. [Huntington's disease: clinical and molecular genetics].
Warita H; Shiro Y; Kashihara K; Abe K
Nihon Rinsho; 1999 Apr; 57(4):896-9. PubMed ID: 10222786
[TBL] [Abstract][Full Text] [Related]
16. Altered selenium status in Huntington's disease: neuroprotection by selenite in the N171-82Q mouse model.
Lu Z; Marks E; Chen J; Moline J; Barrows L; Raisbeck M; Volitakis I; Cherny RA; Chopra V; Bush AI; Hersch S; Fox JH
Neurobiol Dis; 2014 Nov; 71():34-42. PubMed ID: 25014023
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease.
Ona VO; Li M; Vonsattel JP; Andrews LJ; Khan SQ; Chung WM; Frey AS; Menon AS; Li XJ; Stieg PE; Yuan J; Penney JB; Young AB; Cha JH; Friedlander RM
Nature; 1999 May; 399(6733):263-7. PubMed ID: 10353249
[TBL] [Abstract][Full Text] [Related]
18. Cardiac Fas-Dependent and Mitochondria-Dependent Apoptotic Pathways in a Transgenic Mouse Model of Huntington's Disease.
Wu BT; Chiang MC; Tasi CY; Kuo CH; Shyu WC; Kao CL; Huang CY; Lee SD
Cardiovasc Toxicol; 2016 Apr; 16(2):111-21. PubMed ID: 25800750
[TBL] [Abstract][Full Text] [Related]
19. Huntington's disease: From molecular basis to therapeutic advances.
Krobitsch S; Kazantsev AG
Int J Biochem Cell Biol; 2011 Jan; 43(1):20-4. PubMed ID: 21056115
[TBL] [Abstract][Full Text] [Related]
20. Olesoxime suppresses calpain activation and mutant huntingtin fragmentation in the BACHD rat.
Clemens LE; Weber JJ; Wlodkowski TT; Yu-Taeger L; Michaud M; Calaminus C; Eckert SH; Gaca J; Weiss A; Magg JC; Jansson EK; Eckert GP; Pichler BJ; Bordet T; Pruss RM; Riess O; Nguyen HP
Brain; 2015 Dec; 138(Pt 12):3632-53. PubMed ID: 26490331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
